Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Top Performance

Predictions

buy
Alnylam Pharmace.

Start price
Target price
Perf. (%)
€189.54
03.03.23
€390.56
03.03.24
-25.40%
04.03.24

HC Wainwright 
03.03.23 50%
buy
Neurocrine Bioscience

Start price
Target price
Perf. (%)
€95.10
03.03.23
-
03.03.24
26.60%
04.03.24

Evercore ISI 
03.03.23 50%
buy
Fibrogen Inc.

Start price
Target price
Perf. (%)
€2.14
19.02.24
-
19.02.25
-24.30%
03.03.24

Probably not worthwhile Investment
thomasw 
19.02.24 50%
buy
Amicus Therapeutics Inc.

Start price
Target price
Perf. (%)
€12.00
02.03.23
€16.05
02.03.24
0.83%
03.03.24

UBS Group AG 
02.03.23 50%
buy
Omnicell Inc.

Start price
Target price
Perf. (%)
€52.50
02.03.23
€61.39
02.03.24
-53.90%
03.03.24

KeyCorp 
02.03.23 50%
buy
Fibrogen Inc.

Start price
Target price
Perf. (%)
€1.71
24.02.24
-
24.02.25
-5.26%
02.03.24

Could be worthwhile Investment >10% per year
Global_Player 
24.02.24 50%
buy
Masimo Corp.

Start price
Target price
Perf. (%)
€163.70
01.03.23
€185.49
01.03.24
-29.11%
02.03.24

Raymond James 
01.03.23 50%
sell
Fibrogen Inc.

Start price
Target price
Perf. (%)
€1.55
22.02.24
-
22.02.25
4.52%
02.03.24

Very low/no dividend yield expected
Risky Investment
EBIT decline/stagnation expected
High valuation
kostojunior 
22.02.24 0%
buy
Acadia Pharmaceuticals

Start price
Target price
Perf. (%)
€19.63
28.02.23
€23.50
28.02.24
12.07%
29.02.24

HC Wainwright 
28.02.23 50%
buy
Amedisys Inc.

Start price
Target price
Perf. (%)
€85.50
28.02.23
€108.15
28.02.24
-0.58%
29.02.24

Credit Suisse Group AG 
28.02.23 50%
sell
Nektar Therapeutics

Start price
Target price
Perf. (%)
€1.32
28.02.23
€1.88
28.02.24
-50.72%
29.02.24

The Goldman Sachs Group, Inc. 
28.02.23 50%
buy
Omnicell Inc.

Start price
Target price
Perf. (%)
€50.50
27.02.23
€64.25
27.02.24
-52.48%
28.02.24

Benchmark Co. 
27.02.23 50%
buy
Xencor Inc.

Start price
Target price
Perf. (%)
€31.20
26.02.23
-
26.02.24
-21.79%
27.02.24

SVB Leerink LLC 
26.02.23 50%
buy
Fibrogen Inc.

Start price
Target price
Perf. (%)
€0.88
25.01.24
€1.30
25.01.25
143.18%
19.02.24

Could be very worthwhile Investment >20% year
BiotechBee 
25.01.24 50%
sell
Fibrogen Inc.

Start price
Target price
Perf. (%)
€2.02
13.02.24
-
13.02.25
5.94%
17.02.24

Probably not worthwhile Investment
Vassago1 
13.02.24 50%
sell
Fibrogen Inc.

Start price
Target price
Perf. (%)
€1.72
05.02.24
-
05.02.25
24.42%
17.02.24

Very low/no dividend yield expected
Risky Investment
EBIT decline/stagnation expected
High valuation
kostojunior 
05.02.24 0%
buy
Blueprint Medicines Corp

Start price
Target price
Perf. (%)
€64.00
30.11.23
-
30.11.24
10.94%
31.01.24

Saftman 
30.11.23 50%
buy
Neogenomicsinc.

Start price
Target price
Perf. (%)
€17.40
16.05.23
-
16.05.24
-17.82%
31.01.24

Saftman 
16.05.23 50%
buy
Insulet Corp.

Start price
Target price
Perf. (%)
€287.30
13.04.23
-
13.04.24
-38.58%
31.01.24

Saftman 
13.04.23 50%
buy
Sage Therapeutics Inc.

Start price
Target price
Perf. (%)
€37.80
04.04.23
-
04.04.24
-37.04%
31.01.24

Saftman 
04.04.23 50%
buy
Ensign Group Inc.

Start price
Target price
Perf. (%)
€86.00
04.04.23
-
04.04.24
24.42%
31.01.24

Saftman 
04.04.23 50%
buy
Medpace Holdings Inc

Start price
Target price
Perf. (%)
€220.20
24.01.23
-
24.01.24
25.34%
25.01.24

Saftman 
24.01.23 50%
buy
Masimo Corp.

Start price
Target price
Perf. (%)
€178.60
19.04.23
€177.50
19.04.24
-38.97%
27.12.23

Solomon 
19.04.23 80%
buy
Bluebird Bio Inc.

Start price
Target price
Perf. (%)
€4.00
02.12.23
€5.00
31.10.25
-30.50%
10.12.23

Could be very worthwhile Investment >20% year
BiotechBee 
02.12.23 50%
buy
Arrowhead Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€19.62
30.11.23
-
30.11.24
12.62%
08.12.23

Could be very worthwhile Investment >20% year
thomasw 
30.11.23 50%